Screener
Viking Therapeutics VKTX Price / book
Price / book at other companies
Other financials
Where this comes from
Calculated from Viking Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Viking Therapeutics’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 29, 2026, 9:50 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-193315
FAQ
- What is Viking Therapeutics's price / book?
- Viking Therapeutics (VKTX) reported price / book of 7.5× in Q1 2026.
- How has Viking Therapeutics's price / book changed year-over-year?
- Viking Therapeutics's price / book increased by 134.1% year-over-year, from 3.2× to 7.5×.
- What is the long-term trend for Viking Therapeutics's price / book?
- Over 5 years (2020 to 2025), Viking Therapeutics's price / book has grown at a 28.1% compound annual growth rate (CAGR), from 1.8× to 6.2×.
- What does price / book mean?
- Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.
Ask your AI about Viking Therapeutics's price / book.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude